scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.LAB.2005.06.011 |
P698 | PubMed publication ID | 16459164 |
P50 | author | Richard P Allen | Q59195273 |
Christopher J Earley | Q115870570 | ||
P2093 | author name string | James R Connor | |
John L Beard | |||
Stacey L Clardy | |||
P2860 | cites work | Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis | Q48317066 |
P433 | issue | 2 | |
P304 | page(s) | 67-73 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Translational Research | Q15761127 |
P1476 | title | Ferritin subunits in CSF are decreased in restless legs syndrome | |
P478 | volume | 147 |
Q37023585 | A delicate balance: Iron metabolism and diseases of the brain. |
Q37258755 | A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. |
Q36607081 | A new look at an under-diagnosed poorly treated condition: restless legs syndrome. |
Q37836552 | A possible role for secreted ferritin in tissue iron distribution |
Q33486406 | Biophysical mechanisms of phase contrast in gradient echo MRI. |
Q57065781 | Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study |
Q30837083 | CSF proteomic analysis reveals persistent iron deficiency-induced alterations in non-human primate infants |
Q33587212 | Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults |
Q33847248 | Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders |
Q37086225 | Diurnal cycle influences peripheral and brain iron levels in mice |
Q51930607 | Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. |
Q38039480 | European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society |
Q33563777 | Hepcidin antagonists for potential treatments of disorders with hepcidin excess |
Q35880254 | High-field MRI of brain cortical substructure based on signal phase |
Q46054305 | Iron deficiency alters the day-night variation in monoamine levels in mice |
Q37393715 | Iron deficiency anemia in infancy exerts long-term effects on the tibialis anterior motor activity during sleep in childhood. |
Q39150062 | Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome |
Q89864796 | Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome |
Q22251258 | Le syndrome des jambes sans repos |
Q45201265 | Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging |
Q33658871 | Mechanisms of iron metabolism in Caenorhabditis elegans |
Q28566402 | Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons |
Q36800596 | Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study |
Q64088844 | Probable RBD Associates with the Development of RLS in Parkinson’s Disease: A Cross-Sectional Study |
Q34754646 | Profile of altered brain iron acquisition in restless legs syndrome |
Q48095045 | Relationship between hepcidin levels and periodic limb movement disorder in patients with obstructive sleep apnea syndrome |
Q64863934 | Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders? |
Q48416860 | Restless legs syndrome in pediatric patients with chronic kidney disease |
Q53228404 | Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment. |
Q37763512 | Restless legs syndrome: pathophysiology, clinical presentation and management |
Q24626621 | Serum ferritin: Past, present and future |
Search more.